LTB4 ranks with the most potent chemoattractants for leucocytes, complement Sa, and chemotactic tripeptide, f-MLP (unpublished data). This inflammatory mediator and its 20-OH and 20-COOH derivatives are present in significant amounts in rheumatoid joint fluid,6 7 and its activity is markedly lowered for two to three weeks after a single, intra-articular injection of steroid. 7 The aim of the present study was to assess the Table 2 ). Fractionation by TLC showed a twofold increase in the capacity for oxidation of AA by cells from patients with rheumatoid arthritis (Table 3 , Fig. 1 ) with a corresponding increase in the relative contribution of both LTB4 (Table 3 , Fig. 2 ) and its 20-OH and 20-COOH catabolites (Table 3) . These two degradation products of LTB4 were not separated in the TLC system used.
HPLC controls revealed identical specific activities of LTB4 in patients and controls, ranging from 3.4 to 6.9 Bq/mmol. Only trace amounts of 6-trans- LTB4 were identified by HPLC. Little cyclooxygenase activity was found, either in patients or controls, and there was a minor contribution from a metabolite inhibited by indomethacin and identified as 12-hydroxyheptadecatrienoic acid (HHT) ( Table 3) . 12 The main fraction of the residual activity was more lipophilic than AA, possibly indicating ester- ification to cholesterol or glycerol. This fraction was not calculated by laser densitometry. Fig. 3 
